- Home
- ASYS vs NRSN Comparison
ASYS vs NRSN Comparison
Compare ASYS & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- NRSN
- Stock Information
- Founded
- ASYS 1981
- NRSN 2017
- Country
- ASYS United States
- NRSN Israel
- Employees
- ASYS N/A
- NRSN N/A
- Industry
- ASYS Industrial Machinery/Components
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- ASYS Technology
- NRSN Health Care
- Exchange
- ASYS Nasdaq
- NRSN Nasdaq
- Market Cap
- ASYS 68.0M
- NRSN 50.1M
- IPO Year
- ASYS N/A
- NRSN 2021
- Fundamental
- Price
- ASYS $6.33
- NRSN $1.06
- Analyst Decision
- ASYS
- NRSN Buy
- Analyst Count
- ASYS 0
- NRSN 2
- Target Price
- ASYS N/A
- NRSN $14.00
- AVG Volume (30 Days)
- ASYS 81.9K
- NRSN 353.2K
- Earning Date
- ASYS 08-06-2025
- NRSN 09-29-2025
- Dividend Yield
- ASYS N/A
- NRSN N/A
- EPS Growth
- ASYS N/A
- NRSN N/A
- EPS
- ASYS N/A
- NRSN N/A
- Revenue
- ASYS $83,634,000.00
- NRSN N/A
- Revenue This Year
- ASYS N/A
- NRSN N/A
- Revenue Next Year
- ASYS $12.93
- NRSN N/A
- P/E Ratio
- ASYS N/A
- NRSN N/A
- Revenue Growth
- ASYS N/A
- NRSN N/A
- 52 Week Low
- ASYS $3.20
- NRSN $0.68
- 52 Week High
- ASYS $6.50
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- ASYS 67.35
- NRSN 33.59
- Support Level
- ASYS $5.82
- NRSN $1.05
- Resistance Level
- ASYS $6.44
- NRSN $1.17
- Average True Range (ATR)
- ASYS 0.41
- NRSN 0.12
- MACD
- ASYS 0.10
- NRSN 0.01
- Stochastic Oscillator
- ASYS 94.09
- NRSN 10.00
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.